Streptococcus

#Immunology / Virology & Vaccines #Moderna #mRNA-based vaccines #Streptococcus #University of Queensland

Researchers step closer to a universal Strep-A mRNA vaccine

A team of microbiologists and immunologists has completed the first steps towards developing a universal vaccine against Group A Streptococcus (Strep-A).  The University of Queensland-led research in partnership with Moderna and published in Nature Communications has shown Strep-A can be successfully targeted using… Read More

#Editor's Choice #News

Gram positive cocci in chain bacteria, Streptococcus, a type of bacteria
#Biotechnology #Clinical trials #Group B Streptococcus #Immunology / Virology & Vaccines #MinervaX #Streptococcus

Full enrolment for Phase I clinical trial of Group B streptococcus  

MinervaX, a Danish biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus (GBS), has completed enrolment and initial dosing in its Phase I clinical vaccine trial in older adults. The trial is taking place at CEVAC (Centre for Vaccinology), Ghent University, Belgium.  GBS is most… Read More

#News